AKT1 and type 2 diabetes mellitus: We postulate that ALA may alleviate inflammation by suppressing the TNF‐α/JNK pathway and may ameliorate insulin signal transduction by improving the PI3K/AKT pathway, thus increasing muscle generation and reducing muscle degradation, ultimately inhibiting atrophy in the muscle of T2DM rats.